Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -613.00x is 55% below its 5-year average of -394.98x, around the middle of its 5-year range (-966.50x–-12.49x).
As of the fiscal period ended Friday, September 30, 2022. 9.81% above its 12-month average of -679.65x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2022 (2022-09-30): -613.00x.
INTEREST COVERAGE RATIO
-613.00x
INTEREST COVERAGE RATIO AVG TTM
-679.65x
INTEREST COVERAGE RATIO AVG 3Y
-459.66x
INTEREST COVERAGE RATIO AVG 5Y
-394.98x
INTEREST COVERAGE RATIO AVG 10Y
-185.38x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.81%
CURRENT VS 3Y AVG
-33.36%
CURRENT VS 5Y AVG
-55.20%
CURRENT VS 10Y AVG
-230.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 459 covered companies
CURRENT VS SECTOR MEDIAN
-10749.56%
vs the sector median at left
Niagen Bioscience Inc
Market Cap
$214.34M
Interest Coverage Ratio
-613.00x
TTM Avg
-679.65x
3Y Avg
-459.66x
5Y Avg
-394.98x
Market Cap
$214.35M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$215.15M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$213.22M
Interest Coverage Ratio
N/A
TTM Avg
39.15x
3Y Avg
39.15x
5Y Avg
39.15x
Market Cap
$214.63M
Interest Coverage Ratio
N/A
TTM Avg
1274.61x
3Y Avg
1274.61x
5Y Avg
1274.61x
Market Cap
$208.74M
Interest Coverage Ratio
N/A
TTM Avg
4.80x
3Y Avg
4.80x
5Y Avg
4.80x
Market Cap
$206.04M
Interest Coverage Ratio
16.00x
TTM Avg
14.45x
3Y Avg
13.14x
5Y Avg
13.02x
Market Cap
$223.62M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niagen Bioscience Inc (NAGE) | $214.34M | -613.00x | -679.65x | -459.66x | -394.98x |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.35M | N/A | N/A | N/A | N/A |
| Lyell Immunopharma, Inc. (LYEL)vs › | $215.15M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $213.22M | N/A | 39.15x | 39.15x | 39.15x |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.63M | N/A | 1274.61x | 1274.61x | 1274.61x |
| Alector, Inc. (ALEC)vs › | $218.62M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $208.74M | N/A | 4.80x | 4.80x | 4.80x |
| Pro-Dex, Inc. (PDEX)vs › | $206.04M | 16.00x | 14.45x | 13.14x | 13.02x |
| Keros Therapeutics, Inc. (KROS)vs › | $223.62M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $202.26M | N/A | N/A | N/A | N/A |
Interest Coverage
-613.0x
Debt/Equity
0.03
Current Ratio
6.50
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-09-30 | -613.00x |
| 2022-06-30 | -638.70x |
| 2022-03-31 | -966.50x |
| 2021-12-31 | -590.67x |
| 2021-09-30 | -589.40x |
| 2021-06-30 | -462.83x |
| 2021-03-31 | -387.47x |
| 2020-12-31 | -380.06x |
| 2020-09-30 | -220.84x |
| 2020-06-30 | -153.63x |
| 2020-03-31 | -490.83x |
| 2019-09-30 | -21.94x |
| 2019-06-30 | -12.49x |
| 2018-09-30 | -955.11x |
| 2018-06-30 | -165.35x |
| 2018-03-31 | -190.89x |
| 2017-12-31 | -199.35x |
| 2017-09-30 | -70.58x |
| 2017-06-30 | -73.61x |
| 2017-03-31 | -46.77x |
| 2016-12-31 | -79.88x |
| 2016-09-30 | -81.12x |
| 2016-06-30 | 2.55x |
| 2016-03-31 | 2.41x |
| 2015-12-31 | -6.81x |
| 2015-09-30 | 0.97x |
| 2015-06-30 | -1.40x |
| 2015-03-31 | -7.54x |
| 2014-12-31 | -8.87x |
| 2014-09-30 | -52.01x |
| 2014-06-30 | -136.57x |
| 2014-03-31 | -185.90x |
| 2013-12-31 | -72.90x |
| 2013-09-30 | -143.24x |
| 2013-06-30 | -125.68x |
| 2013-03-31 | -181.81x |
| 2012-12-31 | -64.40x |
| 2012-09-30 | -223.11x |
| 2012-06-30 | -527.30x |
| 2012-03-31 | -535.43x |
| 2011-12-31 | -329.51x |
| 2011-09-30 | -8127.75x |
| 2011-06-30 | -223.51x |
| 2011-03-31 | -2645.04x |
| 2010-12-31 | -93.51x |
| 2010-09-30 | -86.25x |
| 2010-06-30 | -27.34x |
| 2010-03-31 | 6.90x |
| 2009-12-31 | -33.86x |
| 2009-09-30 | -44.12x |
| 2009-06-30 | -62.35x |
| 2009-03-31 | -61.05x |
